Breast Cancer Angiogenesis: Therapy Target and Prognostic Factor

By Harris A.L.   Fox S.   Leek R.   Zhang H.   Scott P.   Bicknell R.   Gatter K.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 831-832

Elsevier

Access to resources Recommend Favorite

A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients

By Alsner Jan   Jensen Vibeke   Kyndi Marianne   Vrou Offersen Birgitte   Vu Phuong   Børresen-Dale Anne-Lise   Overgaard Jens  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 600-607

Informa Healthcare

Access to resources Recommend Favorite

Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients

By Kucera E.   Speiser P.   Gnant M.   Szabo L.   Samonigg H.   Hausmaninger H.   Mittlbock   Fridrik M.   Seifert M.   Kubista E.   Reiner A.   Zeillinger R.   Jakesz R.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 398-405

Elsevier

Access to resources Recommend Favorite

p53 expression is a factor for prognostic assessment in breast sarcoma

By Maciel M.d.S.  

Breast Cancer Research and Treatment, Vol. 71, Iss. 3, 2002-02 ,pp. : 193-202

Springer Publishing Company

Access to resources Recommend Favorite

Spectrum of p53 Tumor Suppressor Gene Mutations and Breast Cancer Survival

By Lai Hong  

Breast Cancer Research and Treatment, Vol. 83, Iss. 1, 2004-01 ,pp. : 57-66

Springer Publishing Company

Access to resources Recommend Favorite